Clinical trial
Vyvanse in Children Aged 6 to 12 Years
NCT05416125
Study timeline
Study start (actual)2023-12-20Date precision: day
Registry last updated2026-08-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesity, Childhoodunresolved
Interventions
Lisdexamfetamine DimesylateDRUG · verified · RxNorm: lisdexamfetamine dimesylate
Lifestyle therapyBEHAVIORAL
Sponsors & collaborators
University of Minnesotalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05416125 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.